Metagenomi Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-73.95	-68.26	-43.59	-21.44
Depreciation & Amortization	5.15	4.21	1.73	0.39
Asset Writedown & Restructuring Costs	0.3	0.02	0.28	-
Loss (Gain) From Sale of Investments	-4.39	-11.34	-1.22	-2.56
Stock-Based Compensation	15.26	6.92	1.96	0.38
Other Operating Activities	2.83	3.47	1.08	1.24
Change in Accounts Receivable	3.34	-1.18	-1.27	-
Change in Accounts Payable	-1.06	-0.08	0.72	0.7
Change in Unearned Revenue	-43.62	-30.3	65.66	44.23
Change in Income Taxes	-2.17	1.73	1.54	-
Change in Other Net Operating Assets	-5.07	3.4	2.84	1.33
Operating Cash Flow	-103.39	-91.41	29.72	24.26
Operating Cash Flow Growth	-	-	22.54%	-
Capital Expenditures	-4.52	-9.81	-13.98	-2.9
Investment in Securities	-51.55	55.55	-108.22	-71.41
Investing Cash Flow	-56.07	45.73	-122.2	-74.32
Long-Term Debt Issued	-	-	-	29.97
Net Debt Issued (Repaid)	-	-	-	29.97
Other Financing Activities	-1.33	-3.28	-	-
Financing Cash Flow	82.68	1.01	239.59	39.92
Net Cash Flow	-76.78	-44.66	147.12	-10.14
Free Cash Flow	-107.91	-101.22	15.75	21.35
Free Cash Flow Growth	-	-	-26.26%	-
Free Cash Flow Margin	-195.91%	-226.17%	91.55%	8787.65%
Free Cash Flow Per Share	-4.39	-29.73	4.63	3.75
Cash Interest Paid	6.56	6.56	2.16	1.45
Levered Free Cash Flow	-65.55	-31.65	-19.71	-
Unlevered Free Cash Flow	-65.55	-31.65	-19.65	-
Change in Net Working Capital	26.15	-16.09	-18.53	-

Source: S&P Capital IQ. Standard template. Financial Sources.